Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Troels K, Hansen"'
Autor:
Sara Meziani, Giulia Ferrannini, Mette Bjerre, Troels K. Hansen, Viveca Ritsinger, Anna Norhammar, Viveca Gyberg, Per Näsman, Lars Rydén, Linda G. Mellbin
Publikováno v:
Cardiovascular Diabetology, Vol 21, Iss 1, Pp 1-8 (2022)
Abstract Background Mannose binding lectin (MBL) has been suggested to be associated with an impaired cardiovascular prognosis in dysglycaemic conditions, but results are still contrasting. Our aims are (i) to examine whether MBL levels differ betwee
Externí odkaz:
https://doaj.org/article/d04363d403984f26a06009068c5b3b41
Autor:
Katrine M Lauritsen, Jens Hohwü Voigt, Steen Bønløkke Pedersen, Troels K Hansen, Niels Møller, Niels Jessen, Lars C Gormsen, Esben Søndergaard
Publikováno v:
Endocrine Connections, Vol 11, Iss 4, Pp 1-12 (2022)
SGLT2 inhibition induces an insulin-independent reduction in plasma glucose causing increased lipolysis and subsequent lipid oxidation by energy-consuming tissues. However, it is unknown whether SGLT2 inhibition also affects lip id storage in adipose
Externí odkaz:
https://doaj.org/article/07c525e6ebfb421f8701d94cd30c3b03
Autor:
Kristian L. Funck, Esben Laugesen, Pernille Høyem, Brian Stausbøl-Grøn, Won Y. Kim, Leif Østergaard, Dora Grauballe, Troels K. Hansen, Christian S. Buhl, Per L. Poulsen
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 13, Iss 1, Pp 1-9 (2021)
Abstract Background Stroke is a serious complication in patients with type 2 diabetes (T2DM). Arterial stiffness may improve stroke prediction. We investigated the association between carotid-femoral pulse wave velocity [PWV] and the progression of c
Externí odkaz:
https://doaj.org/article/009282f2bdc641639f53182518ffe900
Autor:
Esben Laugesen, Pernille Høyem, Samuel Thrysoe, Esben Søvsø Szocska Hansen, Anders F. Stegmann Mikkelsen, William S. Kerwin, Per L. Poulsen, Troels K. Hansen, W. Yong Kim
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 7, Iss 16 (2018)
Background Ischemic stroke from carotid plaque embolism remains a major cause of morbidity in patients with type 2 diabetes mellitus (T2DM). However, the effect of early T2DM and obesity on carotid remodeling and plaque burden remains elusive. We ass
Externí odkaz:
https://doaj.org/article/ba3e45cd254243369e6671eeb167d2ac
Autor:
JULIE M. BRØSEN, RIKKE AGESEN, AMRA CIRIC ALIBEGOVIC, HENRIK U. ANDERSEN, PETER GUSTENHOFF, TROELS K. HANSEN, CHRISTOFFER HEDETOFT, CHARLOTTE R. STOLBERG, CLAUS B. JUHL, SUSANNE LERCHE, KIRSTEN NØRGAARD, LISE TARNOW, BIRGER THORSTEINSSON, ULRIK PEDERSEN-BJERGAARD
Publikováno v:
Diabetes. 71
Background and Aims: Insulin Degludec (IDeg) , in comparison with Insulin Glargine U100 (IGla) , reduces the risk of hypoglycemic events in people with type 1 diabetes (T1D) . The impact on CGM assessed glycemic metrics: the coefficient of variation
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7f9cd754e9929008973c4dca2fa0aea
https://doi.org/10.2337/db22-218-or
https://doi.org/10.2337/db22-218-or
Autor:
Kristian L. Funck, Esben Laugesen, Kristian Oevrehus, Jesper M. Jensen, Bjarne L. Noergaard, Damini Dey, Troels K. Hansen, Per L. Poulsen
Publikováno v:
Artery Research, Vol 16 (2016)
Background: Arterial stiffness may provide non-invasive information about cardiovascular risk in patients with type 2 diabetes. We investigated the association between arterial stiffness and subclinical coronary atherosclerosis in patients with type
Externí odkaz:
https://doaj.org/article/75e4e5c16bb24f45af8f679f2168a8c0
Autor:
Ulrik, Pedersen-Bjergaard, Rikke M, Agesen, Julie M B, Brøsen, Amra C, Alibegovic, Henrik U, Andersen, Henning, Beck-Nielsen, Peter, Gustenhoff, Troels K, Hansen, Christoffer, Hedetoft, Tonny J, Jensen, Claus B, Juhl, Andreas K, Jensen, Susanne S, Lerche, Kirsten, Nørgaard, Hans-Henrik, Parving, Anne L, Sørensen, Lise, Tarnow, Birger, Thorsteinsson
Publikováno v:
Diabetes, obesitymetabolism. 24(2)
To investigate whether the long-acting insulin analogue insulin degludec compared with insulin glargine U100 reduces the risk of nocturnal symptomatic hypoglycaemia in patients with type 1 diabetes (T1D).Adults with T1D and at least one episode of no
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::91639fbfb082351938494b7caf79180b
https://pubmed.ncbi.nlm.nih.gov/34643020
https://pubmed.ncbi.nlm.nih.gov/34643020
Autor:
null Ulrik Pedersen‐Bjergaard, null Rikke M. Agesen, null Julie M. B. Brøsen, null Amra C. Alibegovic, null Henrik U. Andersen, null Henning Beck‐Nielsen, null Peter Gustenhoff, null Troels K. Hansen, null Christoffer Hedetoft, null Tonny J. Jensen, null Claus B. Juhl, null Andreas K. Jensen, null Susanne S. Lerche, null Kirsten Nørgaard, null Hans‐Henrik Parving, null Anne L. Sørensen, null Lise Tarnow, null Birger Thorsteinsson
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6858e8af56a1bc4d475904bc206e9f7a
https://doi.org/10.1111/dom.14574/v2/response1
https://doi.org/10.1111/dom.14574/v2/response1
Autor:
Lise Tarnow, Hans-Henrik D. Parving, Amra Ciric Alibegovic, Kirsten Nørgaard, Claus B. Juhl, Julie M. Brøsen, Susanne Lerche, Peter Gustenhoff, Ulrik Pedersen-Bjergaard, Rikke M. Agesen, Troels K. Hansen, Tonny Jensen, Birger Thorsteinsson, Henrik U. Andersen
Publikováno v:
Diabetes. 69
Background and Aims: Nocturnal hypoglycemia is a major source of concern of people with type 1 diabetes (T1D) and may result in suboptimal glycemic control due to avoidance behavior. Optimal basal insulin therapy may reduce nocturnal hypoglycemia. In
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::404f28c25741f5a630d8d22447f5b8ca
https://doi.org/10.2337/db20-270-or
https://doi.org/10.2337/db20-270-or
Autor:
Cristobal Morales Portillo, Matthias G. Von Herrath, Ofri Mosenzon, Thomas R. Pieber, Troels K. Hansen, Janusz Gumprecht, Chantal Mathieu, B Bode, George M. Tsoukas, Stine Segel, Stephen C. Bain, Leylya Gaysina, Ken Coppieters, Jesper Ole Clausen
Publikováno v:
Diabetes. 69
Objective: To evaluate the effect of anti-IL-21 and liraglutide, alone and in combination, compared to placebo, on preservation of β-cell function after 54 weeks of treatment in adults with recently diagnosed type 1 diabetes. Methods: This was a mul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::333a3e77d1006243ed5e6210becb57ab
https://doi.org/10.2337/db20-278-or
https://doi.org/10.2337/db20-278-or